SEK288.20
2.56% yesterday
Stockholm, Sep 19, 05:29 pm CET
ISIN
SE0010323311
Symbol
BIOA B

BioArctic AB Stock price

SEK288.20
+52.60 22.33% 1M
+77.60 36.85% 6M
+88.70 44.46% YTD
+117.10 68.44% 1Y
+186.80 184.22% 3Y
+201.80 233.56% 5Y
+259.20 893.79% 10Y
+259.20 893.79% 20Y
Stockholm, Closing price Fri, Sep 19 2025
+7.20 2.56%
ISIN
SE0010323311
Symbol
BIOA B
Industry

Key metrics

Basic
Market capitalization
SEK24.9b
Enterprise Value
SEK23.0b
Net debt
positive
Cash
SEK1.9b
Shares outstanding
88.5m
Valuation (TTM | estimate)
P/E
23.9 | 25.0
P/S
13.4 | 12.0
EV/Sales
12.4 | 11.1
EV/FCF
21.9
P/B
12.2
Dividends
DPS
SEK0.00
Yield 1Y | 5Y
0.0% | 0.0%
Growth 1Y | 5Y
- | -
Payout 1Y | 3Y
0.0% | 0.0%
Increased
0 Years
Financials (TTM | estimate)
Revenue
SEK1.9b | SEK2.1b
EBITDA
SEK1.2b | SEK1.2b
EBIT
SEK1.2b | SEK1.2b
Net Income
SEK1.1b | SEK1.0b
Free Cash Flow
SEK1.1b
Growth (TTM | estimate)
Revenue
521.2% | 703.6%
EBITDA
- | 662.9%
EBIT
1,323.5% | 630.8%
Net Income
1,308.6% | 677.2%
Free Cash Flow
883.4%
Margin (TTM | estimate)
Gross
97.2%
EBITDA
63.5% | 57.5%
EBIT
63.2%
Net
57.4% | 49.4%
Free Cash Flow
56.5%
Financial Health
Equity Ratio
80.5%
Return on Equity
-19.8%
ROCE
56.7%
ROIC
-
Debt/Equity
0.0
More
EPS
SEK12.1
FCF per Share
SEK11.9
Short interest
-
Employees
107
Rev per Employee
SEK2.4m
Show more

Is BioArctic AB a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,012 stocks worldwide.

BioArctic AB Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a BioArctic AB forecast:

8x Buy
80%
2x Hold
20%

Analyst Opinions

10 Analysts have issued a BioArctic AB forecast:

Buy
80%
Hold
20%

Financial data from BioArctic AB

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
1,860 1,860
521% 521%
100%
- Direct Costs 52 52
47% 47%
3%
1,808 1,808
585% 585%
97%
- Selling and Administrative Expenses 168 168
7% 7%
9%
- Research and Development Expense 361 361
147% 147%
19%
1,181 1,181
-
64%
- Depreciation and Amortization 6.31 6.31
-
0%
EBIT (Operating Income) EBIT 1,175 1,175
1,324% 1,324%
63%
Net Profit 1,067 1,067
1,309% 1,309%
57%

In millions SEK.

Don't miss a Thing! We will send you all news about BioArctic AB directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

BioArctic AB engages in the research and development of modifying treatments and diagnostics for neurodegenerative diseases. Its research areas are Alzheimer’s disease and Parkinson’s disease where there are large unmet medical needs. The company was founded by Lars Gunnar Lannfelt and Pär Lars Gellerfors on January 24, 2003 and is headquartered in Stockholm, Sweden.

Head office Sweden
CEO Gunilla Osswald
Employees 107
Founded 2000
Website www.bioarctic.se

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today